Overexpression of protein kinase C delta represses expression of proliferin in NIH3T3 cells that regulates cell

Y Kang1, J S Park, S H Kim

  • 1Institute for Medical Sciences, Ajou University School of Medicine, Suwon 442-721, Korea.

Insights

Protein kinase C (PKC) delta inhibits cell proliferation by repressing proliferin expression. Overexpression of PKC delta leads to decreased cell growth, suggesting a novel regulatory pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Protein kinase C (PKC) delta is recognized for its role in inhibiting the proliferation of various cell types.
  • Understanding the specific molecular mechanisms underlying PKC delta's antiproliferative effects is crucial.

Purpose of the Study:

  • To identify genes regulated by PKC delta during cell proliferation inhibition.
  • To elucidate the role of proliferin in PKC delta-mediated NIH3T3 cell proliferation.

Main Methods:

  • Differential display-polymerase chain reaction (DD-PCR) was employed to identify differentially expressed genes in PKC delta-overexpressing NIH3T3 cells.
  • Transient transfection assays were performed to assess the relationship between PKC delta and proliferin expression.
  • Neutralization of secreted proliferin using an anti-proliferin antibody was conducted to evaluate its functional impact.

Main Results:

  • Overexpression of PKC delta significantly reduced NIH3T3 cell proliferation.
  • DD-PCR identified proliferin, a known stimulator of cell proliferation, as significantly repressed in PKC delta-overexpressing cells.
  • PKC delta-induced repression of proliferin expression was dose-dependent and inversely correlated with PKC delta levels.
  • Blocking secreted proliferin with an antibody decreased cell proliferation.

Conclusions:

  • PKC delta overexpression leads to the transcriptional repression of proliferin.
  • This repression of proliferin contributes to the inhibition of cell proliferation mediated by PKC delta.
  • PKC delta acts as a negative regulator of proliferin, impacting cell growth.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...